SCHEMBL5370570

SCHEMBL5370570

Cc1ccc(S(=O)(=O)Nc2ccc3oc(-c4ccc(C(C)(C)C)cc4)nc3c2)cc1C(=O)O

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.62
ALDH1A1 P00352 3/20 0.62
MAPT P10636 3/20 0.62
XBP1 P17861 1/20 0.62
PTPN1 P18031 18/20 0.61
PTPN5 P54829 18/20 0.61
PTPN2 P17706 17/20 0.61
MEN1 O00255 2/20 0.61
HPGD P15428 2/20 0.61
KMT2A Q03164 2/20 0.61
GAA P10253 1/20 0.61
ALOX12 P18054 1/20 0.61
NPSR1 Q6W5P4 1/20 0.61
HSPD1 P10809 9/20 0.61
HSPE1 P61604 9/20 0.61
CYP1A2 P05177 1/20 0.56
CYP2D6 P10635 1/20 0.56
CYP2C9 P11712 1/20 0.56
CYP2C19 P33261 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5380699 0.94 PTPN2 (0.58) KDM4EALDH1A1MAPTXBP1PTPN1
SCHEMBL5375215 0.92 PTPN2 (0.65) KDM4EALDH1A1MAPTXBP1PTPN1
SCHEMBL5373826 0.92 PTPN1 (0.74) KDM4EALDH1A1MAPTXBP1PTPN1
SCHEMBL5391237 0.89 PTPN1 (0.59) KDM4EALDH1A1MAPTXBP1PTPN1
SCHEMBL5376608 0.88 HSPD1 (0.60) KDM4EALDH1A1MAPTXBP1PTPN1
SCHEMBL5376503 0.87 PTPN2 (0.69) KDM4EALDH1A1MAPTXBP1PTPN1
SCHEMBL5371930 0.86 PTPN2 (0.60) KDM4EALDH1A1MAPTXBP1PTPN1
SCHEMBL5373561 0.86 PTPN2 (0.62) KDM4EALDH1A1MAPTXBP1PTPN1
SCHEMBL5376831 0.85 PTPN2 (0.66) KDM4EALDH1A1MAPTXBP1PTPN1
SCHEMBL5372072 0.85 PTPN5 (0.64) KDM4EALDH1A1MAPTXBP1PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PFIZER INC 2006-11-16 US disclosed
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD KDM4E 3834/4885ALDH1A1 2956/4885MAPT 1786/4885
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARG, PPARA, PPARD KDM4E 3815/4885ALDH1A1 2752/4885MAPT 1984/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.